Product Details

Veroket is a sterile injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Ketamine Hydrochloride for use as a dissociative anaesthetic through the intramuscular (I.M.) or intravenous (I.V.) route. As a result, it offers rapid-onset anaesthesia and analgesia for a range of surgical, diagnostic, and emergency settings.

The injection contains:

• Ketamine Hydrochloride BP (equivalent to Ketamine 50mg per mL) – An NMDA receptor antagonist that blocks glutamate signalling in the central nervous system. Consequently, it produces a dissociative anaesthetic state with profound analgesia while preserving airway reflexes and cardiovascular stability.

Anaesthetists and emergency physicians use Veroket for the induction and maintenance of anaesthesia, particularly in short surgical and diagnostic procedures. In addition, its rapid onset and airway-preserving profile make it valuable in emergency and field settings. Because of this, Veroket suits operating theatres, emergency departments, and ambulatory surgical units where fast, reliable dissociative anaesthesia is required.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the dual-route (I.M./I.V.) formulation offers flexible clinical use
• Furthermore, each vial delivers precise, validated dosage accuracy at 50mg/mL
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected, single-dose vial packaging preserves product stability
• Ultimately, a reliable supply chain suits bulk distribution to hospitals and emergency care units